Rooted in Violet & Co

GLP-1 Medications and Black Women: A Real-World Guide to Access, Affordability, and Advocacy

GLP-1 Access

GLP-1 Medications, Hype, and the Reality for Black Women

GLP-1 medications like Ozempic, Wegovy, and others are everywhere in the news. They are praised for weight loss and diabetes control, and are even being studied for conditions like heart disease and Alzheimer’s. But behind the headlines is a harder truth: the women who carry some of the highest burdens of obesity and diabetes—Black women—are often the least likely to get access to these drugs.

This blog is not here to tell you that you “must” take a GLP-1. Instead, it is a self-advocacy guide. You’ll learn what these medications do, how often Black women actually receive them, the barriers that stand in the way, and practical steps you can take if you want to explore this option with your care team.

GLP-1 Basics in Plain Language

GLP-1 medications were initially developed to treat type 2 diabetes. They work with your body’s hormones to:

  • Help regulate blood sugar
  • Slow how quickly food leaves your stomach
  • Reduce appetite and cravings

Because of these effects, they are now also used for weight management in people with obesity or overweight, plus certain health conditions. Brand names you may hear include Ozempic, Wegovy, Mounjaro, and Zepbound.

Typically, GLP-1s are prescribed for:

  • People with type 2 diabetes who meet certain lab criteria (such as elevated A1C)
  • People with obesity or overweight, plus conditions like diabetes, high blood pressure, or heart disease

They are powerful tools—but they are not magic, and they are not the only option. They should be part of a bigger plan that includes nutrition, movement, stress care, and mental health support.

The Numbers: GLP-1 Use vs Obesity in Black Women

Black women in the United States have some of the highest rates of obesity and related conditions, yet they are less likely to receive GLP-1 prescriptions.

  • Obesity rates among Black women exceed 55%, the highest of any demographic group.
  • Among adults with obesity, only about 2.3% of non-Hispanic Black adults are prescribed GLP-1 receptor agonists, compared to 2.4% of non-Hispanic White adults.
  • Across all women in the U.S., GLP-1 use is estimated at around 5%, but Black patients overall are still less likely to be prescribed these medications than their White peers.
  • Among adults with diagnosed diabetes, GLP-1 use is roughly 4.3% for Black adults, similar to some other groups, but still low given how common diabetes is in this community.

The key takeaway: Black women are the group most affected by obesity, yet they remain among the least likely to receive GLP-1 prescriptions. This is not about individual willpower. It is about systems, access, and bias.

Why the Gap Exists: Barriers Specific to Black Women

Cost and Insurance Coverage

GLP-1 medications are expensive. Without insurance, monthly costs can range from about $350 to over $1,000. Even with insurance, copays can still be $100–$200 or more.

Many health plans only cover GLP-1s for diabetes, not for obesity alone. Others require strict prior authorization, step therapy, or proof that you have tried and “failed” other treatments first. Medicaid coverage varies widely by state, and Medicare does not currently cover GLP-1s for obesity.

Because Black women are more likely to be uninsured or underinsured, and more likely to work in jobs without generous benefits, these coverage rules hit especially hard.

Structural Racism and Provider Bias

Research shows that Black adults have 30–50% lower odds of receiving GLP-1 prescriptions than White adults, even when they meet the same medical criteria and have similar insurance.

In real life, this can look like:

  • Being told to “just lose weight” instead of being offered medication options
  • Providers assume you cannot afford newer drugs
  • Less aggressive treatment of obesity and diabetes in clinics that primarily serve Black communities

These patterns are part of a long history of Black women’s pain, symptoms, and concerns being minimized or dismissed in healthcare settings.

Socioeconomic Factors

Income, job type, and daily responsibilities all shape access.

  • Higher income and private insurance are strongly associated with greater GLP-1 use.
  • Lower income, unstable work hours, and caregiving responsibilities make it harder to attend multiple appointments, complete lab work, and navigate complicated insurance paperwork.

For many Black women, the question is not just “Is this drug right for me?” but “How can I possibly afford this and still pay rent, childcare, and groceries?”

Geography and Access to Specialists

Where you live matters.

  • Rural and medically underserved areas often have few endocrinologists or obesity medicine specialists.
  • Safety-net and community clinics may have less experience with newer, high-cost medications.

If you live in a community with fewer specialists, you may never even hear GLP-1s mentioned as an option.

Clinical Trial Representation and Trust

Black women are underrepresented in many obesity and weight-loss drug trials. That means:

  • Providers may feel less confident about how these drugs work in Black women.
  • Patients may feel less trust in medications that were not well studied in people who look like them.

This underrepresentation is not a reason to deny care, but it does shape both provider behavior and patient comfort.

Stigma, Body Image, and Cultural Context

Weight stigma is real in healthcare. Many Black women report feeling judged for their weight, their eating habits, or their bodies.

At the same time, cultural norms around body size and beauty can be different in Black communities. Some women worry that seeking weight-loss treatment will be seen as rejecting their culture or their natural body.

Navigating GLP-1s means holding both truths: you can love your body and still want to improve your health. You deserve respectful, non-shaming care either way.

Affordability: Understanding the Financial Landscape

To make an informed decision, you need a clear picture of the money side.

Real-World Cost Scenarios

  • Cash prices range from $350 to $1,200 per month, or $4,000 to $14,000 per year.
  • Even with insurance, copays can be high enough that people stop treatment.
  • As more people use GLP-1s, some employers and insurers are tightening coverage or adding limits to control costs.

When prices go up or coverage changes, many patients stop filling their prescriptions. That can undo progress on blood sugar, weight, and other health goals.

Questions to Ask About Your Coverage

If you are considering a GLP-1, it helps to ask your health plan or HR department:

  • Do you cover GLP-1 medications for diabetes, obesity, or both?
  • Which specific drugs are on your formulary (covered list)?
  • What are the prior authorization or step therapy requirements?
  • What will my monthly copay or coinsurance be?
  • Are there any annual or lifetime limits on GLP-1 use?

Clear answers help you and your provider choose options that are both medically appropriate and financially realistic.

Finding Help: Programs and Strategies to Lower GLP-1 Costs

Even with high prices, some programs can reduce costs for some patients.

Manufacturer Patient Assistance Programs

Several drug manufacturers offer patient assistance programs (PAPs) that provide free or low-cost medication to eligible patients. These programs often support:

  • Uninsured or underinsured patients
  • U.S. citizens or legal residents
  • Households with income below a certain percentage of the federal poverty level

Applications typically require:

  • Proof of income
  • A completed form from you
  • A form completed by your healthcare provider

With approval, the medication ships to your provider’s office.

Savings Cards and Copay Programs

For people with commercial (employer-based or individual) insurance, manufacturer savings cards may significantly reduce copays for a limited time.

Important notes:

  • Medicare and Medicaid usually do not accept these cards.
  • They may have time limits or caps on the total amount of savings.

Discount Tools and Compounded Options

Discount services can sometimes lower the cash price at certain pharmacies. Some telehealth or clinic-based programs offer compounded versions of GLP-1-type medications at lower prices.

If you consider compounded options, it is important to:

  • Ask about the source of the medication
  • Confirm the pharmacy has a proper level of licensure
  • Discuss safety and effectiveness with a trusted provider

Insurance Appeals

If your insurance denies coverage for a GLP-1 your provider recommends, you may have the right to appeal.

A strong appeal often includes:

  • A letter from your provider explaining why the medication is medically necessary
  • Documentation of your health history and previous treatments
  • Any relevant guidelines or evidence supporting the use of a GLP-1 in your situation

Many patients can reduce their out-of-pocket costs after a successful appeal.

Advocacy in the Exam Room: Scripts and Checklists

You deserve to have your questions answered and your options explained. Preparing for your appointment can make these conversations easier.

Preparing for Your Appointment

Before you go, gather:

  • A list of your diagnoses (such as obesity, prediabetes, diabetes, high blood pressure, heart disease)
  • Recent lab results, if you have them (A1C, cholesterol, etc.)
  • A brief history of what you have already tried: lifestyle changes, programs, medications
  • Your insurance card and any information about drug coverage

Go in with the mindset that you are a partner in your care, not a problem to be fixed.

Questions and Phrases You Can Use

To open the conversation:

  • “I’ve been reading about GLP-1 medications for diabetes and weight. Based on my health history, am I a candidate for one of these?”

To ask for clear reasoning:

  • “If you don’t think a GLP-1 is right for me, can you explain why and what alternatives you recommend?”

To bring up cost and assistance:

  • “If we decide a GLP-1 makes sense, can your office help me look into patient assistance programs or prior authorization?”

Responding to Dismissive or Biased Responses

A provider tells you to “just lose weight” without a real discussion of options:

  • “I’ve been working on lifestyle changes for a long time. I’d like to talk about all evidence-based options, including medications. Can we revisit that?”

If cost is used as a reason not to discuss GLP-1s at all:

  • “I understand cost is a concern, but I’d still like to understand what options are medically appropriate. We can then talk through affordability together.”

You feel your concerns are not being taken seriously, it may be time to seek a second opinion, especially from an endocrinologist or obesity medicine specialist if you can access one.

Beyond the Individual: Policy and Community-Level Change

Your personal experience is shaped by bigger forces: drug pricing, insurance rules, employer decisions, and public policy. As GLP-1 use grows, debates about who should get these medications and who should pay for them will continue.

For Black women, these decisions mustn’t widen existing gaps. Expanding coverage for obesity treatment, improving access in Medicaid and Medicare, and addressing racial bias in prescribing are all part of the work.

Ways to engage include:

  • Asking your employer or union how GLP-1 coverage is handled in your health plan
  • Supporting organizations that advocate for equitable obesity and diabetes care
  • Sharing your story with trusted advocacy groups, if and when it feels safe

Putting It All Together: You Deserve Full Information and Fair Access

GLP-1 medications are not a cure-all, but they are an essential tool in the toolbox for diabetes and obesity care. Black women, who bear some of the heaviest burdens of these conditions, deserve:

  • Clear, honest information about how these drugs work
  • A fair chance to be considered for them when medically appropriate
  • Support in navigating cost, coverage, and bias

You are not behind. You are not failing. You are moving through a system that was not built with you in mind—and still, you are advocating for yourself.

At Rooted in Violet & Co., our goal is to stand beside you with stories, scripts, and tools that help you walk into every exam room more prepared and more confident.

In a separate toolkit for our members, we break this down into practical worksheets, conversation scripts, and checklists you can print or save to your phone for your next appointment.